✦ LIBER ✦

Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours

✍ Scribed by Scott, Edwina N; Meinhardt, Gerold; Jacques, Christian; Laurent, Dirk; Thomas, Anne L

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical development of EGFR-tyrosine ki

✍ Kazuhiko Nakagawa 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 268 KB

Clinical Development of Src Tyrosine Kin

✍ David Lee Lee; Oliver Gautschi 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 292 KB

Small Molecule Tyrosine Kinase Inhibitor

✍ Neeltje Steeghs; Johan W. R. Nortier; Hans Gelderblom 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 311 KB

Phase I and pharmacological study of the

✍ Konings, I R H M; de Jonge, M J A; Burger, H; van der Gaast, A; van Beijsterveld 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 302 KB

A rationale for the clinical development

✍ Ann L Jackman; Camille J Melin; Rosemary Kimbell; Lisa Brunton; G.Wynne Aherne; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Tyrosine kinase inhibitors: Why does the

✍ Carlos L. Arteaga; Jose Baselga 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 134 KB